Blue Harbour Group LP Has Lifted Its Mednax (MD) Holding; BIOQUELL PLC (BIQLF) SI Decreased By 95.24%

February 19, 2018 - By Marie Mckinney

BIOQUELL PLC (OTCMKTS:BIQLF) had a decrease of 95.24% in short interest. BIQLF’s SI was 100 shares in February as released by FINRA. Its down 95.24% from 2,100 shares previously. With 100 avg volume, 1 days are for BIOQUELL PLC (OTCMKTS:BIQLF)’s short sellers to cover BIQLF’s short positions. It closed at $3.5 lastly. It is down 0.00% since February 19, 2017 and is . It has underperformed by 16.70% the S&P500.

Blue Harbour Group Lp increased Mednax Inc (MD) stake by 63.97% reported in 2017Q3 SEC filing. Blue Harbour Group Lp acquired 982,600 shares as Mednax Inc (MD)’s stock declined 21.94%. The Blue Harbour Group Lp holds 2.52 million shares with $108.61 million value, up from 1.54 million last quarter. Mednax Inc now has $5.25 billion valuation. The stock increased 0.39% or $0.22 during the last trading session, reaching $56.61. About 711,021 shares traded. MEDNAX, Inc. (NYSE:MD) has declined 18.20% since February 19, 2017 and is downtrending. It has underperformed by 34.90% the S&P500.

Among 18 analysts covering MEDNAX (NYSE:MD), 5 have Buy rating, 1 Sell and 12 Hold. Therefore 28% are positive. MEDNAX had 50 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was maintained by Stephens on Thursday, February 8 with “Buy”. The stock of MEDNAX, Inc. (NYSE:MD) earned “Underperform” rating by Bank of America on Friday, May 5. As per Thursday, June 22, the company rating was upgraded by Stephens. The stock of MEDNAX, Inc. (NYSE:MD) has “Overweight” rating given on Monday, September 18 by KeyBanc Capital Markets. Mizuho maintained MEDNAX, Inc. (NYSE:MD) rating on Tuesday, May 30. Mizuho has “Neutral” rating and $58 target. JP Morgan downgraded the stock to “Neutral” rating in Friday, March 10 report. KeyBanc Capital Markets maintained the shares of MD in report on Monday, December 4 with “Buy” rating. The stock of MEDNAX, Inc. (NYSE:MD) earned “Hold” rating by Jefferies on Thursday, August 31. The firm has “Buy” rating by Jefferies given on Friday, August 26. The stock of MEDNAX, Inc. (NYSE:MD) has “Hold” rating given on Thursday, May 25 by Stifel Nicolaus.

Bioquell PLC designs, manufactures, and supplies bio-decontamination and containment equipment, and related services and products to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. The company has market cap of $. The Company’s bio-decontamination solutions include hydrogen peroxide vapour bio-decontamination equipment and services for the life sciences, healthcare, and defense sectors; chemical, biological, radiological, and nuclear filtration systems and environmental control equipment for military vehicles and fixed facilities; and professional services, including room bio-decontamination services. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: